Form 4: Director Richard Buller Executes Celcuity Stock Options
Statement of Changes in Beneficial Ownership
Director Richard E. Buller exercised 3,000 stock options and sold the resulting shares under a pre-arranged 10b5-1 trading plan.
Summary
- Director Richard E. Buller exercised 3,000 stock options at a strike price of $5.10 per share.
- Following the exercise, the director sold the 3,000 shares in two separate transactions.
- The first sale of 2,325 shares occurred at a weighted average price of $110.1057.
- The second sale of 675 shares occurred at a weighted average price of $110.8268.
- All transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transaction was pre-planned and represents standard portfolio management by a director.
Positives
- The transactions were conducted under a pre-established Rule 10b5-1 trading plan, which is a standard mechanism for insiders to sell stock without concerns regarding non-public information.
Negatives
- The director reduced his indirect beneficial ownership in the company through these sales.
Risks
- The director's reliance on a 10b5-1 plan indicates a scheduled liquidation of equity, which may signal personal financial planning rather than a specific view on company performance.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Industry Context
StockSavvy.ai notes that insider selling via 10b5-1 plans is a common practice for executives and directors to diversify their portfolios, and this specific transaction reflects a significant gain on options granted in 2020.
Comparison to Industry Standards
- The use of 10b5-1 plans is considered the industry standard for corporate insiders to maintain transparency and regulatory compliance during equity divestment.
Stakeholder Impact
- Minimal impact on shareholders as the transaction was executed through a pre-planned 10b5-1 arrangement.
Next Steps
- No future corporate actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 2025-12-08 | Date the Rule 10b5-1 trading plan was adopted. |
| 2026-03-31 | Date of the option exercise and subsequent share sales. |
| 2026-04-02 | Date the Form 4 was filed with the SEC. |
Keywords
Celcuity, CELC, Insider Trading, Form 4, Stock Options, Director Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.